Use of Bemitil in patients with progressive muscular dystrophies
Comparison in people · 1992
- What was studied
- 22 patients with progressive myodystrophy
- Main finding
- Reports changes in lipid peroxidation and discusses glucose metabolism in patients receiving Bemitil.
Reported findings and study design
22 patients with progressive muscular dystrophy treated with Bemitil.
Population or model 22 patients with progressive myodystrophy
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Lipid peroxidation and metabolic exchange | Favorable changes reported | No numerical treatment effect or regimen given |
Values describe this study and its comparison. Unreported effect sizes and missing denominators have not been inferred.
Source for these results ↗ · Reviewed 2026-10-29
Study limitations and source details
Study limitations
- The abstract does not establish a randomized comparison or durable disease-modifying benefit.
- The 1991 and 1992 publications may share patients; they are not assumed to be independent replications.
Source details
Indexed citation and abstract checked; full methods and risk of bias remain unreviewed.
Sources checked
Citation
V. S. Lobzin, L. A. Saikova, M. L. Chukhlovina, V. G. Pustozerov. Use of Bemitil in patients with progressive muscular dystrophies Lik Sprava. (4):85–87. PMID 1441389